Cargando…
MicroRNA-145 regulates oncolytic herpes simplex virus-1 for selective killing of human non-small cell lung cancer cells
BACKGROUND: Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related mortality worldwide, and novel treatment modalities to improve the prognosis of patients with advanced disease are highly desirable. Oncolytic virotherapy is a promising approach for the treatment of advanced NSCLC...
Autores principales: | Li, Jhy-Ming, Kao, Kuo-Chin, Li, Li-Fu, Yang, Tsung-Ming, Wu, Chean-Ping, Horng, Yan-Ming, Jia, William WG, Yang, Cheng-Ta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734208/ https://www.ncbi.nlm.nih.gov/pubmed/23876001 http://dx.doi.org/10.1186/1743-422X-10-241 |
Ejemplares similares
-
Oncolytic herpes simplex virus kills stem-like tumor-initiating colon cancer cells
por: Warner, Susanne G, et al.
Publicado: (2016) -
Oncolytic herpes simplex virus and immunotherapy
por: Ma, Wenqing, et al.
Publicado: (2018) -
Treatment of breast cancer stem cells with oncolytic herpes simplex virus
por: Li, J, et al.
Publicado: (2012) -
Retargeting Strategies for Oncolytic Herpes Simplex Viruses
por: Campadelli-Fiume, Gabriella, et al.
Publicado: (2016) -
Oncolytic Herpes Simplex Virus and PI3K Inhibitor BKM120 Synergize to Promote Killing of Prostate Cancer Stem-like Cells
por: Wang, Lei, et al.
Publicado: (2019)